aTyr Pharma
Gregory Solz is an experienced professional in quality and compliance management, currently serving as the Head of Quality and Compliance at aTyr Pharma since March 2022. Previously held several leadership positions at OncoSec Medical Incorporated, including Vice President of Quality (GxP) and Management Representative. Additional roles include Sr. Director of Clinical Quality Compliance at Orexigen Therapeutics and Director of Quality Assurance at Neothetics. Gregory has also contributed to quality assurance at Therapeutics, Inc., Chiltern International, Inovio Pharmaceuticals Inc., Magellan Laboratories, and Elan Pharmaceuticals. Gregory holds a Bachelor of Science degree in Engineering/Industrial Management from San Diego State University.
This person is not in any teams
aTyr Pharma
aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways.